FDA approves Victrelis for Hepatitis C

Posted by Food and Drug Administration--Press Releases on Friday May 13, 2011 Under News

The U.S. Food and Drug Administration today approved Victrelis (boceprevir) to treat certain adults with chronic hepatitis C. Victrelis is used for patients who still have some liver function, and who either have not been previously treated with drug therapy for their hepatitis C or who have failed such treatment. Victrelis is approved for use in combination with peginterferon alfa and ribavirin.

Be Sociable, Share!

Comments are closed.